A cluster randomized trial to assess the impact of clinical pathways for patients with stroke: rationale and design of the Clinical Pathways for Effective and Appropriate Care Study [NCT00673491]

Massimiliano Panella, Sara Marchisio, Antonella Barbieri, Francesco Di Stanislao, Massimiliano Panella, Sara Marchisio, Antonella Barbieri, Francesco Di Stanislao

Abstract

Background: Patients with stroke should have access to a continuum of care from organized stroke units in the acute phase, to appropriate rehabilitation and secondary prevention measures. Moreover to improve the outcomes for acute stroke patients from an organizational perspective, the use of multidisciplinary teams and the delivery of continuous stroke education both to the professionals and to the public, and the implementation of evidence-based stroke care are recommended. Clinical pathways are complex interventions that can be used for this purpose. However in stroke care the use of clinical pathways remains questionable because little prospective controlled data has demonstrated their effectiveness. The purpose of this study is to determine whether clinical pathways could improve the quality of the care provided to the patients affected by stroke in hospital and through the continuum of the care.

Methods: Two-arm, cluster-randomized trial with hospitals and rehabilitation long-term care facilities as randomization units. 14 units will be randomized either to arm 1 (clinical pathway) or to arm 2 (no intervention, usual care). The sample will include 238 in each group, this gives a power of 80%, at 5% significance level. The primary outcome measure is 30-days mortality. The impact of the clinical pathways along the continuum of care will also be analyzed by comparing the length of hospital stay, the hospital re-admissions rates, the institutionalization rates after hospital discharge, the patients' dependency levels, and complication rates. The quality of the care provided to the patients will be assessed by monitoring the use of diagnostic and therapeutic procedures during hospital stay and rehabilitation, and by the use of key quality indicators at discharge. The implementation of organized care will be also evaluated.

Conclusion: The management of patients affected by stroke involves the expertise of several professionals, which can result in poor coordination or inefficiencies in patient treatment, and clinical pathways can significantly improve the outcomes of these patients. It is proposed that this study will test a new hypothesis and provide evidence of how clinical pathways can work.

Trial registration: ClinicalTrials.gov ID [NCT00673491].

Figures

Figure 1
Figure 1
Flow diagram of the progress of the units through the trial.

References

    1. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008;371:1612–1623. doi: 10.1016/S0140-6736(08)60694-7.
    1. Bejot Y, Benatru I, Rouaud O, Fromont A, Besancenot JP, Moreau T, Giroud M. Epidemiology of stroke in Europe: geographic and environmental differences. J Neurol Sci. 2007;262:85–88. doi: 10.1016/j.jns.2007.06.025.
    1. American Heart Association American Stroke association. Hearth Disease and Stroke Statistics 2008 Update At-a-Glance
    1. Schwamm LH, Pancioli A, Acker JE, 3rd, Goldstein LB, Zorowitz RD, Shephard TJ, Moyer P, Gorman M, Johnston SC, Duncan PW, Gorelick P, Frank J, Stranne SK, Smith R, Federspiel W, Horton KB, Magnis E, Adams RJ, American Stroke Association's Task Force on the Development of Stroke Systems Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke. 2005;36:690–703. doi: 10.1161/01.STR.0000158165.42884.4F.
    1. Saposnik G, Fang J, O'Donnell M, Hachinski V, Kapral MK, Hill MD, on behalf of the Investigators of the Registry of the Canadian Stroke Network (RCSN) for the Stroke Outcome Research Canada (SORCan) Working Group. Escalating Levels of Access to In-Hospital Care and Stroke Mortality. Stroke. 2008, Jul 10.
    1. Kalra L, Evans A, Perez I, Knapp M, Swift C, Donaldson N. A randomised controlled comparison of alternative strategies in stroke care. Health Technol Assess. 2005;18:1–79.
    1. Kjellström T, Norrving B, Shatchkute A. Helsingborg Declaration 2006 on European stroke strategies. Cerebrovasc Dis. 2007;23:231–41. doi: 10.1159/000099633.
    1. Kwan J. Care Pathways for acute stroke care and stroke rehabilitation: From theory to evidence. J Clin Neurosci. 2007;14:189–200. doi: 10.1016/j.jocn.2006.01.026.
    1. European Pathways Association (EPA). Clinical/Care Pathways
    1. Panella M, Brambilla R, Marchisio S, Di Stanislao F. Reducing Stroke In-hospital Mortality: Organized Care is a Complex Intervention. Stroke
    1. Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, Tyrer P. Framework for design and evaluation of complex interventions to improve health. Br Med J. 2000;321:694–696. doi: 10.1136/bmj.321.7262.694.
    1. Loeb MB. Application of the development stages of a cluster randomized trial to a framework for valuating complex health interventions. BMC Health Serv Res. 2002;2:13–21. doi: 10.1186/1472-6963-2-13.
    1. Medical Research Council . Cluster randomized trials: methodological and ethical considerations. London: Medical Research Council; 2002.
    1. Panella M, Marchisio S, Gardini A, Di Stanislao F. A cluster randomized controlled trial of a clinical pathway for hospital treatment of heart failure: study design and population. BMC Health Serv Res. 2007;7:179. doi: 10.1186/1472-6963-7-179.
    1. Fisher M. Stroke and TIA: epidemiology, risk factors, and the need for early intervention. Am J Manag Care. 2008;14:S204–S211.
    1. Worp HB Van der, van Gijn J. Clinical practice. Acute ischemic stroke. N Engl J Med. 2007;357:572–579. doi: 10.1056/NEJMcp072057.
    1. Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ. Methods for evaluating area-wide and organization-based interventions in health and health care: a systematic review. Health Technol Assess. 1999;3
    1. Campbell MK, Mollison J, Grimshaw JM. Cluster trials in implementation research: estimation of intracluster correlation coefficients and sample size. Stat Med. 2001;20:391–399. doi: 10.1002/1097-0258(20010215)20:3<391::AID-SIM800>;2-Z.
    1. Yudkin PL, Moher M. Putting theory into practice: a cluster randomized trial with a small number of clusters. Stat Med. 2001;20:341–349. doi: 10.1002/1097-0258(20010215)20:3<341::AID-SIM796>;2-G.
    1. Panella M, Marchisio S, Di Stanislao F. Reducing clinical variations with clinical pathways: do pathways work? Int J Qual Health Care. 2003;15:509–521. doi: 10.1093/intqhc/mzg057.
    1. Stroke Prevention and Educational Awareness Diffusion (SPREAD) Collaboration: The Italian guidelines for stroke prevention and management
    1. Twisk JWR. Applied Multilevel Analysis A Practical Guide. Cambridge: Cambridge University Press; 2006.
    1. Campbell MJ, Donner A, Klar N. Developments in cluster randomized trials and Statistics in Medicine. Stat Med. 2007;26:2–19. doi: 10.1002/sim.2731.
    1. Donner A, Klar N. Pitfalls of and controversies in cluster randomization trials. Am J Public Health. 2004;94:416–422.
    1. Hawe P, Shiell A, Riley T. Complex interventions: how "out of control" can a randomised controlled trial be? Br Med J. 2004;328:1561–1563. doi: 10.1136/bmj.328.7455.1561.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever